Allopurinol in Acute Coronary Syndrome
A Single-center, Prospective, Randomized, Double-blind, Controlled Trial for the Effect of Allopurinol Sustained-release Capsules on the Stability of Coronary Plaques in Patients With Acute Coronary Syndrome
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
A PHASE4 clinical study on Acute Coronary Syndrome, this trial is completed. The trial is conducted by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology and has accumulated 8 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Aug 2025 — Sep 2025 [monthly]
Completed PHASE4
-
Sep 2024 — Aug 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2022 — Jul 2024 [monthly]
Completed PHASE4
Status: Recruiting → Completed
▶ Show 3 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2018 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
For direct contact, visit the study record on ClinicalTrials.gov .